The impact of the COVID-19 pandemic on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP

Preprint

Agnieszka Lemanska, Colm Andrews, Louis Fisher, Ben Butler-Cole, Amir Mehrkar, Keith J Roberts, Ben Goldacre, Alex J Walker and Brian MacKenna

medRxiv

Cold Spring Harbor Laboratory

16/09/2022

Metrics

18 Record Views

Title: The impact of the COVID-19 pandemic on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP
Creators: Agnieszka Lemanska - University of Surrey
Colm Andrews - University of Oxford
Louis Fisher - University of Oxford
Ben Butler-Cole - University of Oxford
Amir Mehrkar - University of Oxford
Keith J Roberts - University of Birmingham
Ben Goldacre - University of Oxford
Alex J Walker - University of Oxford
Brian MacKenna - University of Oxford
Publication Details: medRxiv
Publisher: Cold Spring Harbor Laboratory
Identifiers: 99783527502346
Academic Unit: School of Health Sciences
Language: English
Resource Type: Preprint